Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pivotal, Multicenter, Blinded, Sham Procedure-Controlled Trial of Renal Denervation by the Peregrine System™ Kit, in Subjects With Hypertension

NCT02910414 is registered in ClinicalTrials.gov with Ablative Solutions, Inc. as lead sponsor.

NCT NCT02910414
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02910414 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pivotal, Multicenter, Blinded, Sham Procedure-Controlled Trial of Renal Denervation by the Peregrine System™ Kit, in Subjects With Hypertension
Lead sponsor
Ablative Solutions, Inc.
Phase
Phase 3
Overall status
Active, not recruiting
Start date
July 22, 2019
Completion date
May 31, 2026
Enrollment
300 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension